miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
出版年份 2019 全文链接
标题
miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-11
DOI
10.1038/s41598-019-54289-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- c‐Myb Promotes Growth and Metastasis of Colorectal Cancer Through c‐fos induced Epithelial mesenchymal transformation
- (2019) Xiao Qu et al. CANCER SCIENCE
- Downregulation of LINC00894-002 Contributes to Tamoxifen Resistance by Enhancing the TGF-β Signaling Pathway
- (2018) Xiulei Zhang et al. BIOCHEMISTRY-MOSCOW
- Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects
- (2018) Tatiana Anatolievna Bogush et al. CANCER INVESTIGATION
- Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors
- (2018) Jamie N Mills et al. CURRENT OPINION IN PHARMACOLOGY
- lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling
- (2018) Runzhou Zhuang et al. MOLECULAR CARCINOGENESIS
- DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-Myb acetylation upon matrix stiffening
- (2017) Daehwan Kim et al. Scientific Reports
- Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features
- (2017) Hiroki Sato et al. Scientific Reports
- Female breast cancer incidence and mortality in China, 2013
- (2017) Ting-Ting Zuo et al. Thoracic Cancer
- miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
- (2016) NOBUHIKO NISHIJIMA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-503 represses epithelial–mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb
- (2016) Xinzhen Guo et al. TUMOR BIOLOGY
- Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
- (2015) Shota Tanaka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Loss of miR-200 family in 5-fluorouracil resistant colon cancer drives lymphendothelial invasiveness in vitro
- (2015) D. Senfter et al. HUMAN MOLECULAR GENETICS
- The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
- (2015) Anamaria Brozovic et al. Molecular Oncology
- Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
- (2015) Ewa Kopczyńska Wspolczesna Onkologia-Contemporary Oncology
- A Family of Pleiotropically Acting MicroRNAs in Cancer Progression, miR-200: Potential Cancer Therapeutic Targets
- (2014) Hai-Feng Zhang et al. CURRENT PHARMACEUTICAL DESIGN
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation
- (2013) Marco Pieraccioli et al. CELL CYCLE
- Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
- (2013) Aamir Ahmad et al. Journal of Hematology & Oncology
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
- (2013) Tissa T. Manavalan et al. PLoS One
- Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
- (2012) A Ward et al. ONCOGENE
- ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer
- (2012) Irene K. Guttilla et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+breast cancer cells
- (2011) Vincenzo Cesi et al. CELL CYCLE
- miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
- (2009) L. Adam et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started